Novel osmotin attenuates glutamate-induced synaptic dysfunction and neurodegeneration via the JNK/PI3K/Akt pathway in postnatal rat brain

por Shah, S A, Lee, H Y, Bressan, R A, Yun, D J, Kim, M O
Publicado 2014

Successful treatment in the patient with serum sodium level greater than 200 mEq/L.

por Park, Y. J., Kim, Y. C., Kim, M. O., Ruy, J. H., Han, S. W., Kim, H. J.
Publicado 2000

Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits

por Shah, S A, Yoon, G H, Chung, S S, Abid, M N, Kim, T H, Lee, H Y, Kim, M O
Publicado 2017

Eosinophilic fasciitis preceding relapse of peripheral T-cell lymphoma.

por Kim, H., Kim, M. O., Ahn, M. J., Lee, Y. Y., Jung, T. J., Choi, I. Y., Kim, I. S., Park, C. K.
Publicado 2000

Neuroprotective effect of osmotin against ethanol-induced apoptotic neurodegeneration in the developing rat brain

por Naseer, M I, Ullah, I, Narasimhan, M L, Lee, H Y, Bressan, R A, Yoon, G H, Yun, D J, Kim, M O
Publicado 2014

1571P COVID-19 positivity rates in patients with an active cancer diagnosis in the University of California Cancer Consortium

por Hong, J., Borno, H.T., Harismendy, O., Yousefi, S., Cinar, P., Rugo, H.S., Kim, M-O., Koshkin, V.S., Bailey, A., McKay, R.R., Small, E.J.
Publicado 2021